VP, Prin. Accounting Officer Michael Vincent Meluzio sold $32K of Cue Biopharma, Inc.

Sold$32,089

$28.05Price

1,144Shares

−2%Stake

What CUE did after the filing

Prices for CUE after this filing aren't in yet.

Traded Mon, Oct 12. Filed Wed, Oct 14, 9:38 PM ET, after the close. Not investment advice.